LifeVantage Corporation announced that it will enter the Portuguese market on May 2026, bringing its full flagship product line—including Protandim, TrueScience Liquid Collagen, MindBody, and P84—to consumers and independent consultants.
The move is part of LifeVantage’s broader European strategy, adding Portugal to a network that already includes the United Kingdom, Germany, the Netherlands, Austria, Spain, Belgium, Ireland, France, and Italy. Portugal offers a growing wellness market and a strategic foothold in Southern Europe, positioning the company to capture new customer segments and diversify its geographic revenue mix.
LifeVantage will deploy its independent consultant model in Portugal, supported by the Evolve Compensation Plan. Consultants will generate income through product sales and by building their own teams, a structure that has driven growth in other international markets and is expected to accelerate adoption of the company’s nutrigenomics‑based products in the new country.
The expansion comes as LifeVantage reports mixed recent financial performance. Q1 fiscal 2026 revenue rose 0.7% year‑over‑year to $47.6 million, while Q4 fiscal 2025 revenue grew 12.6% to $55.1 million. Gross profit margins have remained strong at roughly 79.5%–79.9%, but commissions and incentive expenses account for 43%–44.9% of revenue. The company’s CEO, Steve Fife, announced his retirement effective April 2026, a transition that underscores the need for new growth initiatives such as the Portugal launch.
In a recent earnings call, Fife highlighted the company’s strong momentum, noting that second‑quarter fiscal 2025 revenue surged 31.3% to $67.8 million, driven by demand for the MindBody GLP‑1 System introduced in October. The positive trajectory supports the decision to expand into new markets and signals confidence in the company’s product pipeline and direct‑selling model.
LifeVantage plans to roll out its full product portfolio in Portugal by May 2026, with a phased approach that will begin with Protandim and TrueScience Liquid Collagen before adding MindBody, P84, and other offerings. The company expects the expansion to broaden its customer base, strengthen its direct‑selling network, and contribute to long‑term revenue growth as it continues to navigate a competitive wellness landscape.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.